Laboratory Workup of Amyloidosis
This guideline summarizes the available evidence on the diagnosis and workup of systemic amyloidosis in tissue samples, including the challenges and limitations of common approaches and techniques. Recommendations for pathologists and laboratories receiving these samples are provided.
Authors
- Gregary T. Bocsi
- Vanda F. Torous (ORCID: https://orcid.org/0000-0002-8771-6743)
- Pallavi P. Gopal (ORCID: https://orcid.org/0000-0003-4708-8479)
- Marisol Hernandez (ORCID: https://orcid.org/0000-0002-9804-6853)
- Ellen D. McPhail (ORCID: https://orcid.org/0000-0001-6918-3376)
- Dylan V. Miller (ORCID: https://orcid.org/0000-0003-3129-5748)
- Tanja Kalicanin
- Allison Zemek
- Megan O. Nakashima (ORCID: https://orcid.org/0000-0002-8127-7663)
- Anthony Chang (ORCID: https://orcid.org/0000-0002-6901-3278)
- Maria M. Picken (ORCID: https://orcid.org/0000-0002-8065-6178)
- Kunal Bhatt (ORCID: https://orcid.org/0009-0009-6044-9663)
- Lesley Souter
- Billie Fyfe
Institutions
- Intermountain Healthcare (US)
- Loyola University Medical Center (US)
- Cleveland Clinic (US)
- Mayo Clinic (US)
- College of American Pathologists (US)
- Emory University Hospital (US)
- Johnson University (US)
- Yale University (US)
- University of Chicago Medical Center (US)
- Massachusetts General Hospital (US)
- Kaiser Foundation Hospital (US)
- Kaiser Foundation Hospital (US)
- Smiths Detection (Canada) (CA)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- Archives of Pathology & Laboratory Medicine
- Published
- 2025-11-24
- DOI
- https://doi.org/10.5858/arpa.2025-0275-cp
- Citations
- 1
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- GlaxoSmithKline
- Alexion Pharmaceuticals
- Cleveland Clinic
- Ionis Pharmaceuticals
- Mersana Therapeutics
- Apellis Pharmaceuticals
- Servier
- Genentech